Clinical Trials Insight: 700028319
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 May 2008
At a glance
- Drugs Interleukin-2; IPH 1101
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Innate Pharma
- 23 May 2008 Results will be presented at the Gamma Delta T cell conference in Marseille according to an Innate Pharma media release.
- 23 May 2008 Results have been reported in an Innate Pharma media release.
- 23 May 2008 Primary efficacy endpoint not reached according to an Innate Pharma media release.